Skip to content

ZS Pharma, Inc.

Delisted

CIK 1459266fmd_00J2T7K7A15DXHDG9D2R4Z56SRManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Sep 30, 2015, 12 periods

Income Statement · Annual · Millions · USD
Line itemFY2012FY2013FY2014
Research and development72546
Operating income(8)(32)(61)
Interest expense201
Interest and investment income000
Income tax expense000
Net income(10)(34)(64)